The Experts for TLR agonists and antagonists

Innaxon develops and manufactures defined “Immunoceuticals” of the highest activity and purity for pre-clinical research and development applications for vaccine adjuvants and immuno-therapy. Our unique biological and synthetic Toll-like Receptor (TLR) ligands are well-characterized and effective biological response modifiers of inappropriate or disproportionate immune responses.